Renal Biomarker Market
Global Renal Biomarker Market Research, By Type (Diagnostic Biomarkers, Prognostic Biomarkers, Predictive Biomarkers, Pharmacodynamic Biomarkers), By Diagnostic technique (Elisa, Colorimetric Assay, Liquid Chromatography-Mass Spectrometry, Particle-Enhanced Turbidimetric Immunoassay), By End-User Industry (Hospitals, Diagnostic Labs, Research Centres), and Forecast 2022-2028
The global renal biomarker market is growing at a considerable CAGR of 8.7% during the forecast period. The major factors fuelling the global renal biomarkers market are the increasing number of people with kidney diseases. Rising incidence of multiple co-morbidities, and increasing generic population across the globe. Increasing incidence of chronic diseases such as high blood pressure, diabetes, and obesity also boosts market growth. As these diseases are often associated with the measured loss of kidney function. Furthermore, Growing investments in research and development will further drive the market growth, as renal biomarkers are generally used in preclinical and clinical trials, to assess the safety of new drugs. Furthermore, the increasing demand for clinical diagnosis in cancer’s early stages propels the usage rates of diagnostic biomarkers. According to the WHO, in 2018, cancer was the second leading cause of mortalities around the globe. It is also estimated that 1 out of 6 fatalities was caused by cancer in 2018, an estimated 9.8 million cancer fatalities across the globe. As per the WHO, one-third of all the mortalities from cancer was caused due to the behavioral and dietary risk including low fruit and vegetable intake, high body mass index, lack of physical activity,
For instance, In March 2021, Bioporto diagnostics A/S an in-vitro diagnostic company. The company is focused on the flagship NGAL acute kidney-injury test. BioPorto says its NGAL Test can identify AKI in critically ill patients as quickly as 2 hours. NGAL is the first AKI biomarker that can be measured in both human urine, and plasma and can run on standard chemistry analyzers. That aid in reducing the risk of renal failure or mortality. As per Bioporto, the test can take 72 hours to detect injury to the kidney.
Impact of COVID-19 on the Renal Biomarker Market
The global renal biomarkers market is hardly hit by the outbreak of COVID-19 since December 2019. Hence the outbreak of COVID-19 in the UK disrupts the global supply chain, hence impacting the Renal Biomarker s market negatively. Only the ones who needed urgent treatment for the cancer were diagnosed. However, the market is expected to grow at a faster rate in the forecast period. The market will witness “W” shape recovery in near future owing to the restart of key industries in major economies.
Segmental Outlook
The market is segmented based on type, Diagnostic Technique, and end-user. Based on type, the market is segmented into diagnostic biomarkers, prognostic biomarkers, predictive biomarkers, and pharmacodynamic biomarkers. Based on diagnostic techniques, the market is segmented into elisa, colorimetric assay, liquid chromatography-mass spectrometry, and particle-enhanced turbidimetric immunoassay. By end-user, the market is segmented into hospitals, diagnostic labs, and research centers.
Global Renal Biomarker Market Share by End-User, 2020 (%)
Based on the biomarker type, the functional biomarker has the largest market share. Chronic kidney disease (CKD) has become a global health problem. According to the National Institute of Diabetes, Digestives, and Kidney Diseases, the general occurrence of CKD in people is around 14%, and around 6,61,000 Americans have kidney failure. Presently, the diagnosis of CKD is made by the challenging levels of a functional biomarker, serum creatinine (SCr). Functional Biomarkers include Serum Creatinine, Urine Albumin, and Serum Cystatin is a more significant segment. Vast use in various diagnosis processes and comparatively less cost are driving the growth of this segment.
Regional Outlooks
The global Renal Biomarker market is analyzed based on the geographical regions that are contributing significantly to the growth of the market. Based on the geography, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America held a considerable share in 2020 in the global Renal Biomarker market. Some factors that are boosting the market growth in North America are the increasing diseases such as hypertension, and Diabetes in the region. The US holds the largest market share. There has been major growth in the number of US FDA-approved drug labels holding information on molecular biomarkers. Additionally, increasing investment in R&D is another factor that is promoting the growth of the market.
Global Renal Biomarker Market, by Region 2021-2027
Asia-Pacific is Expected to Hold Considerable Share in the Global Renal Biomarker Market
The Asia-Pacific region is expected to witness significant growth opportunities for the market. The increasing occurrence of kidney diseases in the region, and the increasing generic population derive the growth of the renal biomarkers market in the region. China and India are considered to provide a high range of opportunities for the renal biomarkers market, and growing awareness regarding the benefits of biomarkers for treating chronic diseases such as the ability of biomarkers to target the patient-specific molecular structure enhancing the early stage of disease detection & screening as well as to detect the type of disease is also expected to boost the growth of the Asia-Pacific market in the upcoming scenario.
Market Player Outlook
Key players in the global Renal Biomarker market are Abbott Laboratories, Bayer AG, Novartis AG, Pacific Biomarkers, Siemens AG, and others. These players adopt different marketing strategies such as product launches. For Instance, in April 2021, Biognosys announced an agreement with Siemens. The purpose of the agreement is to speed up the range of diagnostic biomarker innovation by examining the development and clinical testing. The agreement influences Biognosys’ proficiency in balanced biomarker discovery technologies, and solutions with Siemens Healthineers’ biomarker examination expansion, lab testing, and commercialization capabilities.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global renal biomarker market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Renal Biomarker Market
• Recovery Scenario of Global Renal Biomarker Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.2. Abbott Laboratories
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Bayer AG
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Novartis AG
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Pacific Biomarkers
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Siemens AG
3.6.1. Overview
3.6.2. Financial Analysis
3.6.3. SWOT Analysis
3.6.4. Recent Developments
3.7. Key Strategy Analysis
3.8. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Renal Biomarker Market by Type
4.1.1. Diagnostic Biomarkers
4.1.2. Prognostic Biomarkers
4.1.3. Predictive Biomarkers
4.1.4. Pharmacodynamic Biomarkers
4.2. Global Renal Biomarker Market by Diagnostic Technique
4.2.1. Elisa
4.2.2. Colorimetric Assay
4.2.3. Liquid Chromatography-Mass Spectrometry
4.2.4. Particle-Enhanced Turbidimetric Immunoassay
4.3. Global Renal Biomarker Market by End-Users
4.3.1. Hospitals
4.3.2. Diagnostic Labs
4.3.3. Research Centres
5. Regional Analysis
5.1. North America
5.1.1. US
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profile
6.1. Abbott Laboratories
6.2. Astellas Pharma Inc.
6.3. Astute Medical, Inc.
6.4. Bayer AG
6.5. Beckman Coulter Inc.
6.6. Bio Preventive Medicine Corp.
6.7. Biomérieux SA
6.8. Bioporto A/S
6.9. Enzo Life Sciences, Inc.
6.10. Evotec A.G.
6.11. Myriad Genetics Inc.
6.12. Novartis AG
6.13. Pacific Biomarkers
6.14. Plato Bio Pharma Inc.
6.15. Pliant Therapeutics, Inc.
6.16. R & D Systems
6.17. Randox Laboratories Ltd.
6.18. Roche Diagnostics
6.19. Siemens AG
6.20. Thermo Fisher Scientific Inc.
1. GLOBAL RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
2. GLOBAL DIAGNOSTIC BIOMARKERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL PROGNOSTIC BIOMARKERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL PREDICTIVE BIOMARKERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL PHARMACODYNAMIC BIOMARKERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TECHNIQUE, 2021-2028 ($ MILLION)
7. GLOBAL ELISA RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL COLORIMETRIC ASSAY RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL INFLAMMATORY HEART DISEASEMARKET RESEARCH AND ANALYSIS BY END-USERS, 2021-2028 ($ MILLION)
12. GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13. GLOBAL DIAGNOSTIC LABS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
14. GLOBAL RESEARCH CENTRES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
15. GLOBAL RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
16. NORTH AMERICAN RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
17. NORTH AMERICAN RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
18. NORTH AMERICAN RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TECHNIQUE, 2021-2028 ($ MILLION)
19. NORTH AMERICAN RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY END-USERS, 2021-2028 ($ MILLION)
20. EUROPEAN RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
21. EUROPEAN RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
22. EUROPEAN RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TECHNIQUE, 2021-2028 ($ MILLION)
23. EUROPEAN RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY END USERS, 2021-2028 ($ MILLION)
24. ASIA-PACIFIC RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
25. ASIA-PACIFIC RENAL BIOMARKE RMARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
26. ASIA-PACIFIC RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TECHNIQUE, 2021-2028 ($ MILLION)
27. ASIA-PACIFIC RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY END USERS, 2021-2028 ($ MILLION)
28. REST OF THE WORLD RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
29. REST OF THE WORLD RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
30. REST OF THE WORLD RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TECHNIQUE, 2021-2028 ($ MILLION)
31. REST OF THE WORLD RENAL BIOMARKER MARKET RESEARCH AND ANALYSIS BY END USERS, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL RENAL BIOMARKER MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL RENAL BIOMARKER MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL RENAL BIOMARKER MARKET, 2022-2028 (%)
4. GLOBAL RENAL BIOMARKER MARKET SHARE BY TYPE, 2021 VS 2028 (%)
5. GLOBAL DIAGNOSTIC BIOMARKERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL PROGNOSTIC BIOMARKERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL PREDICTIVE BIOMARKERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL PHARMACODYNAMIC BIOMARKERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL RENAL BIOMARKER MARKET SHARE BY DIAGNOSTIC TECHNIQUE, 2021 VS 2028 (%)
10. GLOBAL ELISA RENAL BIOMARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11. GLOBAL COLORIMETRIC ASSAY RENAL BIOMARKERMARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY RENAL BIOMARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY RENAL BIOMARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14. GLOBAL RENAL BIOMARKER MARKET SHARE BY END-USERS, 2021 VS 2028 (%)
15. GLOBAL HOSPITALS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
16. GLOBAL DIAGNOSTIC LABS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
17. GLOBAL RESEARCH CENTRES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
18. GLOBAL RENAL BIOMARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
19. US RENAL BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
20. CANADA RENAL BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
21. UK RENAL BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
22. FRANCE RENAL BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
23. GERMANY RENAL BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
24. ITALY RENAL BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
25. SPAIN RENAL BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
26. REST OF EUROPE RENAL BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
27. INDIA RENAL BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
28. CHINA RENAL BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
29. JAPAN RENAL BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
30. SOUTH KOREA RENAL BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
31. REST OF ASIA-PACIFIC RENAL BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
32. REST OF THE WORLD RENAL BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
